Compare C.H. Robinson Worldwide, Inc. (CHRW) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
C.H. Robinson Worldwide, Inc. vs Cassava Sciences Inc — how do they compare? C.H. Robinson Worldwide, Inc. trades at $196.94 (market cap $23.53B), while Cassava Sciences Inc trades at $1.1 (market cap $52.66M). The key difference: C.H. Robinson Worldwide, Inc. is far larger — about 446.8× Cassava Sciences Inc's market cap, and C.H. Robinson Worldwide, Inc. pays a 1.26% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| CHRW | FLNA | |
|---|---|---|
Market Cap | $23.53B | $52.66M |
Sector | Industrials | Health |
52-Week High | $200.59 | $4.64 |
52-Week Low | $96.82 | $1.09 |
Enterprise Value | $25.02B | -$33.92M |
Dividend Yield | 1.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FLNA trades at $1.15, down 2.54% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company continues to report losses, with a net income of -$90.97M in 2025 and negative cash flow, though it has beaten EPS estimates for the last three quarters. Recent news highlights ongoing development in its TSC-related epilepsy therapies.
Despite consistent earnings beats, FLNA's negative profitability and cash burn pose significant risks. Analyst sentiment is positive with a 66.7% buy rating, but the stock's outlook depends heavily on clinical success and future funding. Investors should weigh the high-risk, high-reward nature of this biotech play.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C.H. Robinson Worldwide, Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
